Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;27(1):28-33.
doi: 10.1038/s41591-020-01202-8. Epub 2021 Jan 13.

Immune determinants of COVID-19 disease presentation and severity

Affiliations

Immune determinants of COVID-19 disease presentation and severity

Petter Brodin. Nat Med. 2021 Jan.

Abstract

COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases. The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women. In contrast to other respiratory viral infections, young children seem to be less severely affected. It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible. In contrast to severe acute COVID-19, such 'long COVID' is seemingly more likely in women than in men. Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection. Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. van Doremalen, N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 382, 1564–1567 (2020). - PubMed - DOI
    1. Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020). - PubMed - PMC - DOI
    1. Wölfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465–469 (2020). - PubMed - DOI
    1. Moghadas, S. M. et al. The implications of silent transmission for the control of COVID-19 outbreaks. Proc. Natl Acad. Sci. USA 117, 17513–17515 (2020). - PubMed - DOI - PMC
    1. Brodin, P. Why is COVID‐19 so mild in children? Acta Paediatr. 109, 1082–1083 (2020). - PubMed - DOI

MeSH terms

Supplementary concepts